Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity

Journal of Clinical Investigation

Volumn 122, Issue 10, 2012, Pages 3769-3780

  Grier, Jennifer T ^a   Forbes, Lisa R ^a   Monaco Shawver, Linda ^a   Oshinsky, Jennifer ^b   Atkinson, T Prescott ^c   Moody, Curtis ^d   Pandey, Rahul ^a   Campbell, Kerry S ^b   Orange, Jordan S ^e  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; HISTIDINE; LYSINE; RITUXIMAB;

ADOLESCENT; AMINO ACID SUBSTITUTION; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CELL KILLING; CELL LINE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENETIC ASSOCIATION; HERPES VIRUS; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL SYNAPSE; MALE; MELANOMA CELL; MISSENSE MUTATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADOLESCENT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD2; CELL LINE; CELL LINE, TUMOR; CHILD, PRESCHOOL; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENOTYPE; GIANT LYMPH NODE HYPERPLASIA; GPI-LINKED PROTEINS; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGICAL SYNAPSES; KILLER CELLS, NATURAL; MALE; MELANOMA; MODELS, MOLECULAR; MUTATION, MISSENSE; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; RECEPTORS, IGG; YOUNG ADULT;

EID: 84867177624     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64837     Document Type: Article

References (44)

1. Bryceson YT, et al. Molecular mechanisms of natural killer cell activation. J Innate Immun. 2011;3(3):216-226.
2. Lanier LL, Phillips JH, Testi R. Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur J Immunol. 1989;19(4):775-778.
3. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503-510.
4. Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;8(9):713-725.
5. Lanier LL, Cwirla S, Yu G, Testi R, Phillips JH. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science. 1989;246(4937):1611-1613.
6. Lanier L, Ruitenberg J, Phillips J. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988;141(10):3478-3485.
7. Hibbs M, Tolvanen M, Carpen O. Membrane-proximal Ig-like domain of Fc gamma RIII (CD16) contains residues critical for ligand binding. J Immunol. 1994;152(9):4466-4474.
8. Tamm A, Schmidt R. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding. J Immunol. 1996;157(4):1576-1581.
9. Lanier LL, Yu G, Phillips JH. Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation. J Immunol. 1991;146(5):1571-1576.
10. Perussia B, Trinchieri G. Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. J Immunol. 1984;132(3):1410- 1415.
11. O'Shea JJ, Weissman AM, Kennedy IC, Ortaldo JR. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci U S A. 1991;88(2):350-354.
12. Perussia B, et al. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol. 1984;133(1):180-189.
13. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002;4(15):1545-1558.
14. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol. 2006;6(6):399-409.
15. Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 suppl 1):S1-S63.
16. Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin Exp Immunol. 1996;103(3):408-413.
17. de Vries E, et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood. 1996;88(8):3022-3027.
18. Comans-Bitter WM, et al. Immunophenotyping of blood lymphocytes in childhoodReference values for lymphocyte subpopulations. J Pediatr. 1997;130(3):388-393.
19. Sondermann P, Huber R, Oosthuizen V, Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature. 2000;406(6793):267-273.
20. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
21. Binyamin L, Alpaugh RK, Hughes TL, Lutz CT, Campbell KS, Weiner LM. Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy. J Immunol. 2008;180(9):6392-6401.
22. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A. 1999;96(10):5640-5644.
23. Wyss DF, et al. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science. 1995;269(5228):1273-1278.
24. Banerjee PP, Orange JS. Quantitative measurement of F-actin accumulation at the NK cell immunological synapse. J Immunol Methods. 2010;355(1-2):1-13.
25. Inoue H, et al. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-γ following CD2 stimulation. Eur J Immunol. 2002;32(8):2188-2198.
26. Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, Strominger JL. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci U S A. 2003;100(24):14151-14156.
27. Moingeon P, et al. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci U S A. 1992;89(4):1492-1496.
28. Vivier E, Morin PM, O'Brienm C, Schlossman SF, Anderson P. CD2 is functionally linked to the ζ-natural killer recεptor complex. Eur J Immunol. 1991;21(4):1077-1080.
29. Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat Rev Immunol. 2011;11(10):645-657.
30. Winkelstein JA, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193-202.
31. Lenart M, et al. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism. Int J Mol Med. 2010;26(3):435-442.
32. Ravetch JV, Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med. 1989;170(2):481-497.
33. Timonen T, Gahmberg C, Patarroyo M. Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Int J Cancer. 1990;46(6):6.
34. Umehara H, et al. Role for adapter proteins in costimulatory signals of CD2 and IL-2 on NK cell activation. Mol Immunol. 2002;38(8):587-596.
35. Lakshmikanth T, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest. 2009;119(5):1251-1263.
36. McKenzie RS, Simms PE, Helfrich BA, Fisher RI, Ellis TM. Identification of a novel CD56-lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2. Cancer Res. 1992;52(22):6318-6322.
37. Casado J, et al. Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines. Cancer Immunol Immunother. 2009;58(9):1517-1526.
38. Altomonte M, et al. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993;53(14):3343-3348.
39. Wang JH, et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell. 1999;97(6):791-803.
40. Bryceson YT, March ME, Ljunggren H-G, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107(1):159-166.
41. van Montfrans JM, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol. 2012;129(3):787-793 e786.
42. Orange JS, et al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest. 2011;121(4):1535-1548.
43. Bates PA, Kelley LA, MacCallum RM, Sternberg MJE. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins. 2001;suppl 5:39-46.
44. Contreras-Moreira B, Bates PA. Domain Fishing: a first step in protein comparative modelling. Bioinformatics. 2002;18(8):1141-1142.